SNF.Back to Markets
Emerging

SNF Emerging Watchlist™

Research and monitoring of newly public companies positioned around emerging economic themes.

SNF Emerging Watchlist(TM) tracks newly public companies positioned around emerging economic themes. Inclusion reflects SNF research interest and ongoing monitoring; it is not a recommendation to buy, sell, or hold a security.

New Research Report
SNF Emerging Watchlist™ - October 2026
23 active companies, three newly admitted Candidates, six expanded research profiles and the evidence that could change each thesis.
View ReportDownload PDF
Watching
14
Candidates
9
Last Review
Oct 24, 2026
Themes
8
Biotechnology / Health Innovation 10AI Infrastructure 4Cybersecurity 2Defense Technology / Space Systems 2Financial Infrastructure / Fintech 2AI software / design systems 1Next-Generation Software 1Nuclear / Advanced Energy 1

Watching

Companies formally admitted to SNF Emerging Watchlist for ongoing research and monitoring.

14 Names
FIGR
Figure Technology Solutions, Inc. - NASDAQ
Watching
Financial Infrastructure / FintechNext-Generation SoftwareInnovative Consumer
Emerging Score
88/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Integrating Kiavi while sustaining marketplace credit quality and growth
CRCL
Circle Internet Group, Inc. - NYSE
Watching
Financial Infrastructure / FintechNext-Generation SoftwareInnovative Consumer
Emerging Score
86/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20269 evidence

Structural Theme Relevance

Primary Risk
Turning Arc and expanded USDC distribution into durable non-reserve revenue
IOND
Ionic Digital Inc. - Nasdaq
Watching
AI InfrastructureData CentersHPC Infrastructure
Emerging Score
86/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Executing the 700 MW Ward County energization path and converting contracted power into durable AI/HPC leasing revenue
LYNX
Lyntris Inc. - NYSE
Watching
Defense Technology / Space SystemsSensorsSpace ISR
Emerging Score
86/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Executing a rapidly expanding defense backlog while integrating the combined platform
CBRS
Cerebras Systems, Inc. - NASDAQ
Watching
AI InfrastructureSemiconductorsData Centers
Emerging Score
85/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Scaling manufacturing and cloud capacity while preserving unit economics
SAIL
SailPoint, Inc. - NASDAQ
Watching
CybersecurityNext-Generation SoftwareFinancial Infrastructure / Fintech
Emerging Score
85/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Sustaining ARR growth while narrowing the GAAP profitability gap
NTSK
Netskope, Inc. - NASDAQ
Watching
CybersecurityNext-Generation SoftwareAI Infrastructure
Emerging Score
85/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 23, 20268 evidence

Structural Theme Relevance

Primary Risk
Sustaining ARR growth while converting scale into durable profitability
HNGE
Hinge Health, Inc. - NYSE
Watching
Biotechnology / Health InnovationNext-Generation SoftwareInnovative Consumer
Emerging Score
84/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Structural Theme Relevance

Primary Risk
Multi-condition expansion and Cylinder integration
OMDA
Omada Health, Inc. - NASDAQ
Watching
Biotechnology / Health InnovationNext-Generation SoftwareInnovative Consumer
Emerging Score
83/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Executing long-term growth and margin targets through the CEO transition
FIG
Figma, Inc. - NYSE
Watching
AI software / design systemsProduct development platformDesign collaboration
Emerging Score
83/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Structural Theme Relevance

Primary Risk
AI infrastructure cost, stock-based compensation and margin pressure
STDN
Standard Nuclear, Inc. - NYSE
Watching
Nuclear / Advanced EnergyPower InfrastructureDefense / Aerospace
Emerging Score
83/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 23, 202612 evidence

Structural Theme Relevance

Primary Risk
Backlog conversion, facility authorization and production scale-up
CRWV
CoreWeave, Inc. - NASDAQ
Watching
AI InfrastructureData CentersNext-Generation Software
Emerging Score
82/100
Confidence
94%
Strong Emerging ProfileReviewed Oct 23, 20268 evidence

Structural Theme Relevance

Primary Risk
Financing intensity, leverage and potential shareholder dilution
CAI
Caris Life Sciences, Inc. - NASDAQ
Watching
Biotechnology / Health InnovationNext-Generation SoftwareAI Infrastructure
Emerging Score
82/100
Confidence
91%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Reimbursement and adoption of molecular profiling and early-detection products
MNTN
MNTN, Inc. - NYSE
Watching
Next-Generation SoftwareInnovative ConsumerAI Infrastructure
Emerging Score
80/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Reaccelerating top-line growth while defending the Performance TV category

Research Candidates

Companies under active SNF research that have not yet been formally admitted to Watching.

9 Names
IAM
Iambic Therapeutics, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationAI Drug DiscoveryPrecision Oncology
Emerging Score
85/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 24, 20266 evidence

AI-enabled drug discovery platform with a clinical pipeline, partner validation and substantial post-IPO runway.

Primary Risk
Translating early clinical activity into durable efficacy while funding a broad pipeline
ADRX
ADARx Pharmaceuticals, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationRNA TherapeuticsRare Disease
Emerging Score
83/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Structural Theme Relevance

Primary Risk
Phase 3 STOP-HAE execution and clinical readout risk
BLSM
BlossomHill Therapeutics, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationOncologyTargeted Therapies
Emerging Score
83/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Growth / Traction

Primary Risk
Early-stage oncology execution and durability of response data
APMD
Apnimed, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationSleep MedicineOral Therapeutics
Emerging Score
82/100
Confidence
93%
Strong Emerging ProfileReviewed Oct 23, 20267 evidence

Structural Theme Relevance

Primary Risk
Binary FDA approval risk and single-asset concentration ahead of February 28, 2027 PDUFA
ACCV
Accelevation Holdings Corp. - Nasdaq
Candidate
AI InfrastructureData CentersPower Infrastructure
Emerging Score
82/100
Confidence
91%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Structural Theme Relevance

Primary Risk
Converting a large data-center backlog into revenue without project cancellations or margin erosion
TRXB
TRex Bio, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationImmunologyTreg Therapeutics
Emerging Score
82/100
Confidence
91%
Strong Emerging ProfileReviewed Oct 24, 20266 evidence

Tissue-Treg platform with Phase 1a proof of mechanism, a patient trial underway and Lilly validation.

Primary Risk
Proving patient-level efficacy for TRB-061 beyond healthy-volunteer proof of mechanism
AMRO
Amaero Inc. - Nasdaq
Candidate
Defense Technology / Space SystemsAdvanced ManufacturingCritical Materials
Emerging Score
81/100
Confidence
90%
Strong Emerging ProfileReviewed Oct 24, 20266 evidence

Domestic specialty-alloy manufacturing with rapid revenue growth, backlog and expanded Tennessee capacity.

Primary Risk
Converting backlog into profitable production while funding a capital-intensive manufacturing ramp
LTGO
Latigo Biotherapeutics, Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationNon-Opioid PainIon Channels
Emerging Score
80/100
Confidence
92%
Strong Emerging ProfileReviewed Oct 23, 20266 evidence

Structural Theme Relevance

Primary Risk
Phase 3 execution and reproducing efficacy at pivotal scale
SCTX
Scribe Therapeutics Inc. - Nasdaq
Candidate
Biotechnology / Health InnovationCRISPRCardiometabolic Gene Editing
Emerging Score
80/100
Confidence
91%
Strong Emerging ProfileReviewed Oct 23, 20268 evidence

Structural Theme Relevance

Primary Risk
First-in-human execution for STX-1150 and proving clinical translation of the platform